Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q1 2026 Earnings Call Transcript May 6, 2026
Tarsus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.16, expectations were $-0.40033.
Operator: Good afternoon, and welcome to Tarsus Pharmaceuticals, Inc. First Quarter 2026 Financial Results Conference Call. As a reminder, this call is being recorded and all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. At...
